Clinical Trial: A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229950) titled 'A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease' on Sept. 29.

Brief Summary: This study is a randomized, double-blind, placebo-controlled Phase II clinical trial comprising screening period, treatment period, and follow-up period. This phase 2 study is being conducted to evaluate the efficacy, safety and pharmacokinetics of HRS-7085 in patients with moderate to severe active ulcerative colitis.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Adult Patients With Moderately to Severely Active Ulcerative Colitis

Inter...